AC Followed by Docetaxel/Trastuzumab Regimen

Preferred Label : AC Followed by Docetaxel/Trastuzumab Regimen;

NCIt synonyms : Doxorubicin/Cyclophosphamide Followed by Docetaxel/Trastuzumab; AC-T Plus Trastuzumab; AC Followed by Docetaxel Trastuzumab; AC-TH; Doxorubicin/Cyclophosphamide Followed by Docetaxel Trastuzumab; AC-Docetaxel Trastuzumab; AC-Taxotere/Herceptin;

NCIt related terms : AC-TH (Docetaxel);

NCIt definition : A chemotherapy regimen consisting of cyclophosphamide and doxorubicin followed by docetaxel and trastuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL525008;

Codes from synonyms : 37198;

Details

Origin ID

C138029;

UMLS CUI

C4527338;

False automatic mappings
- ACTH [ICD-11 Extension code]
- ACTH [MedDRA LLT]
- acth [ATC Code]
- adrenocorticotropic hormone [MeSH Descriptor]
- proopiomelanocortin [ORDO Gene]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Docetaxel [NCIt concept]
- Doxorubicin [NCIt concept]
- Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients